0
0
12/4/22 at 2:30pm
Organization
Medical Dialogues
Author
Medha Baranwal
44 words
0
Comments
Germany: A recent study comparing apixaban and vitamin K antagonist (VKA) in atrial fibrillation (AF) patients on hemodialysis revealed no differences in safety or efficacy outcomes. AF patients
You are the first to view
https://medicaldialogues.in/cardiology-ctvs/news/are-non-vitamin-k-oral-anticoagulants-feasible-for-patients-with-atrial-fibrillation-on-hemodialysis-103165
Create an account
or login to join the discussion